Peter Lundbäck

Peter Lundbäck

Auto-generated profile, based on publicly available information

Peter Lundbäck

Cytiva, Björkgatan 30, Uppsala, Sweden

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2012 in Nature
Verified
Journal Article
Open access
PDF file
BLBen Lu
Ben Lu
TNTakahisa Nakamura
Takahisa Nakamura
KIKaren Inouye
Karen Inouye
JLJianhua Li
Jianhua Li
YTYiting Tang
Yiting Tang
KTKevin J. Tracey
Kevin J. Tracey
Double-stranded RNA-dependent protein kinase (PKR) is shown to be a key regulator of the inflammasome; PKR is central for caspase-1 activation and the release of interleukin (IL)-1β, IL-18 and high-mobility group box 1 (HMGB1) in response to a diverse range of stimuli. The inflammasome, an intracellular oligomeric protein complex involved in innate immunity, has been linked to the pathogenesis of obesity, type 2 diabetes, atherosclerosis, gout, sepsis and colitis. This paper identifies the double-stranded RNA-dependent protein kinase (PKR) as an important regulator of inflammasome activation. PKR autophosphorylation is required for its interaction with the Nod-like receptor NLRP3, for caspase 1 activation and for the release of the cytokines interleukin (IL)-1β, IL-18 and HMGB1 in response to a diverse set of stimuli. This finding raises the possibility of designing therapeutics to inhibit inflammasome activity in inflammatory conditions without broadly impairing immunity. The inflammasome regulates the release of caspase activation-dependent cytokines, including interleukin (IL)-1β, IL-18 and high-mobility group box 1 (HMGB1)1,2,3,4,5. By studying HMGB1 release mechanisms, here we identify a role for double-stranded RNA-dependent protein kinase (PKR, also known as EIF2AK2) in inflammasome activation. Exposure of macrophages to inflammasome agonists induced PKR autophosphorylation. PKR inactivation by genetic deletion or pharmacological inhibition severely impaired inflammasome activation in response to double-stranded RNA, ATP, monosodium urate, adjuvant aluminium, rotenone, live Escherichia coli, anthrax lethal toxin, DNA transfection and Salmonella typhimurium infection. PKR deficiency significantly inhibited the secretion of IL-1β, IL-18 and HMGB1 in E. coli-induced peritonitis. PKR physically interacts with several inflammasome components, including NOD-like receptor (NLR) family pyrin domain-containing 3 (NLRP3), NLRP1, NLR family CARD domain-containing protein 4 (NLRC4), absent in melanoma 2 (AIM2), and broadly regulates inflammasome activation. PKR autophosphorylation in a cell-free system with recombinant NLRP3, apoptosis-associated speck-like protein containing a CARD (ASC, also known as PYCARD) and pro-caspase-1 reconstitutes inflammasome activity. These results show a crucial role for PKR in inflammasome activation, and indicate that it should be possible to pharmacologically target this molecule to treat inflammation.

7 November 2011 in Molecular Medicine
Verified
Journal Article
Open access
HYHuan Yang
Huan Yang
PLPeter Lundbäck
Peter Lundbäck
LOLars Ottosson
Lars Ottosson
HEHelena Erlandsson-Harris
Helena Erlandsson-Harris
EVEmilie Venereau
Emilie Venereau
DADaniel J. Antoine
Daniel J. Antoine
High mobility group box 1 (HMGB1) is a nuclear protein with extracellular inflammatory cytokine activity. It is released passively during cell injury and necrosis, and secreted actively by immune cells. HMGB1 contains three conserved redox-sensitive cysteine residues: C23 and C45 can form an intramolecular disulfide bond, whereas C106 is unpaired and is essential for the interaction with Toll-Like Receptor (TLR) 4. However, a comprehensive characterization of the dynamic redox states of each cysteine residue and of their impacts on innate immune responses is lacking. Using tandem mass spectrometric analysis, we now have established that the C106 thiol and the C23-C45 disulfide bond are required for HMGB1 to induce nuclear NF-κB translocation and tumor necrosis factor (TNF) production in macrophages. Both irreversible oxidation to sulphonates and complete reduction to thiols of these cysteines inhibited TNF production markedly. In a proof of concept murine model of hepatic necrosis induced by acetaminophen, during inflammation, the predominant form of serum HMGB1 is the active one, containing a C106 thiol group and a disulfide bond between C23 and C45, whereas the inactive form of HMGB1, containing terminally oxidized cysteines, accumulates during inflammation resolution and hepatic regeneration. These results reveal critical posttranslational redox mechanisms that control the proinflammatory activity of HMGB1 and its inactivation during pathogenesis.

27 January 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
BLBen Lu
Ben Lu
DADaniel J. Antoine
Daniel J. Antoine
KKKevin Kwan
Kevin Kwan
PLPeter Lundbäck
Peter Lundbäck
HWHeidi Wähämaa
Heidi Wähämaa
KTKevin J. Tracey
Kevin J. Tracey
Significance: High-mobility group box (HMGB)1 is a nuclear protein that we have identified as a proinflammatory mediator during infection or sterile tissue injury, which importantly orchestrates the innate immune responses. The mechanisms of HMGB1 release require translocation of HMGB1 from nucleus to cytoplasm and release into the extracellular space. We recently reported that the inflammasome and PKR mediates HMGB1 release from the cytoplasm, but the mechanism of HMGB1 translocation from nucleus to cytoplasm was previously unknown. Here, we describe our discovery that JAK/STAT1 is required for LPS- or interferon-induced HMGB1 nuclear translocation. These findings have significant implications for the field, and for designing therapeutics for potential use in inflammatory diseases.

5 January 2015 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
HYHuan Yang
Huan Yang
HWHaichao Wang
Haichao Wang
ZJZhongliang Ju
Zhongliang Ju
ARAhmed A. Ragab
Ahmed A. Ragab
PLPeter Lundbäck
Peter Lundbäck
YAYousef Al-Abed
Yousef Al-Abed
Innate immune receptors for pathogen- and damage-associated molecular patterns (PAMPs and DAMPs) orchestrate inflammatory responses to infection and injury. Secreted by activated immune cells or passively released by damaged cells, HMGB1 is subjected to redox modification that distinctly influences its extracellular functions. Previously, it was unknown how the TLR4 signalosome distinguished between HMGB1 isoforms. Here we demonstrate that the extracellular TLR4 adaptor, myeloid differentiation factor 2 (MD-2), binds specifically to the cytokine-inducing disulfide isoform of HMGB1, to the exclusion of other isoforms. Using MD-2–deficient mice, as well as MD-2 silencing in macrophages, we show a requirement for HMGB1-dependent TLR4 signaling. By screening HMGB1 peptide libraries, we identified a tetramer (FSSE, designated P5779) as a specific MD-2 antagonist preventing MD-2–HMGB1 interaction and TLR4 signaling. P5779 does not interfere with lipopolysaccharide-induced cytokine/chemokine production, thus preserving PAMP-mediated TLR4–MD-2 responses. Furthermore, P5779 can protect mice against hepatic ischemia/reperfusion injury, chemical toxicity, and sepsis. These findings reveal a novel mechanism by which innate systems selectively recognize specific HMGB1 isoforms. The results may direct toward strategies aimed at attenuating DAMP-mediated inflammation while preserving antimicrobial immune responsiveness.

1 September 2014 in Pain
Verified
Journal Article
Closed access
NANilesh M. Agalave
Nilesh M. Agalave
MLMax Larsson
Max Larsson
SASally Abdelmoaty
Sally Abdelmoaty
JSJie Su
Jie Su
ABAzar Baharpoor
Azar Baharpoor
CSCamilla I. Svensson
Camilla I. Svensson
Extracellular high mobility group box-1 protein (HMGB1) plays important roles in the pathogenesis of nerve injury- and cancer-induced pain. However, the involvement of spinal HMGB1 in arthritis-induced pain has not been examined previously and is the focus of this study. Immunohistochemistry showed that HMGB1 is expressed in neurons and glial cells in the spinal cord. Subsequent to induction of collagen antibody-induced arthritis (CAIA), Hmgb1 mRNA and extranuclear protein levels were significantly increased in the lumbar spinal cord. Intrathecal (i.t.) injection of a neutralizing anti-HMGB1 monoclonal antibody or recombinant HMGB1 box A peptide (Abox), which each prevent extracellular HMGB1 activities, reversed CAIA-induced mechanical hypersensitivity. This occurred during ongoing joint inflammation as well as during the postinflammatory phase, indicating that spinal HMGB1 has an important function in nociception persisting beyond episodes of joint inflammation. Importantly, only HMGB1 in its partially oxidized isoform (disulfide HMGB1), which activates toll-like receptor 4 (TLR4), but not in its fully reduced or fully oxidized isoforms, evoked mechanical hypersensitivity upon i.t. injection. Interestingly, although both male and female mice developed mechanical hypersensitivity in response to i.t. HMGB1, female mice recovered faster. Furthermore, the pro-nociceptive effect of i.t. injection of HMGB1 persisted in Tlr2- and Rage-, but was absent in Tlr4-deficient mice. The same pattern was observed for HMGB1-induced spinal microglia and astrocyte activation and cytokine induction. These results demonstrate that spinal HMGB1 contributes to nociceptive signal transmission via activation of TLR4 and point to disulfide HMGB1 inhibition as a potential therapeutic strategy in treatment of chronic inflammatory pain.

7 December 2012 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
SNSanna Nyström
Sanna Nyström
DADaniel J Antoine
Daniel J Antoine
PLPeter Lundbäck
Peter Lundbäck
JLJohn G Lock
John G Lock
ANAndreia F Nita
Andreia F Nita
SASteven Applequist
Steven Applequist
Infection of macrophages by bacterial pathogens can trigger Toll‐like receptor (TLR) activation as well as Nod‐like receptors (NLRs) leading to inflammasome formation and cell death dependent on caspase‐1 (pyroptosis). Complicating the study of inflammasome activation is priming. Here, we develop a priming‐free NLRC4 inflammasome activation system to address the necessity and role of priming in pyroptotic cell death and damage‐associated molecular pattern (DAMP) release. We find pyroptosis is not dependent on priming and when priming is re‐introduced pyroptosis is unaffected. Cells undergoing unprimed pyroptosis appear to be independent of mitochondrial involvement and do not produce inflammatory cytokines, nitrous oxide (NO), or reactive oxygen species (ROS). Nevertheless, they undergo an explosive cell death releasing a chemotactic isoform of the DAMP high mobility group protein box 1 (HMGB1). Importantly, priming through surface TLRs but not endosomal TLRs during pyroptosis leads to the release of a new TLR4‐agonist cysteine redox isoform of HMGB1. These results show that pyroptosis is dominant to priming signals and indicates that metabolic changes triggered by priming can affect how cell death is perceived by the immune system.